comparemela.com

Latest Breaking News On - Stephen scala - Page 1 : comparemela.com

Zoetis (ZTS) Q4 2023 Earnings Call Transcript

ZTS earnings call for the period ending December 31, 2023.

United statesBalaji prasad barclaysChris schottMichael ryskinStephen scalaChris schott jpmorganAmerica merrill lynchWilliam blairBalaji prasadGoldman sachsPiper sandlerKristin peckWetteny josephSteve frankErin wright morgan stanleyErin wright

Zoetis (ZTS) Q4 2023 Earnings Call Transcript

ZTS earnings call for the period ending December 31, 2023.

United statesBrandon vazquez william blairAmerica merrill lynchErin wright morgan stanleyElanco quattroBalaji prasadSteve frankBrandon vasquezWilliam blairBalaji prasad barclaysChris schottMichael ryskinStephen scalaKristin peckDave westenberg piper sandlerErin wright

Novartis Ag (NVS) Q4 2023 Earnings Call Transcript

NVS earnings call for the period ending December 31, 2023.

United statesMark purcell morgan stanleyMatthew westonAndrew baum citiPeter welford jefferiesFlorent cespedesSeamus fernandezPeter welfordSamir shahSimon bakerHarry kirschJohn priestnerGoogle deepmindAmerica merrill lynchRichard parkes exaneFlorent cespedes societe generale

Novartis Ag (NVS) Q4 2023 Earnings Call Transcript

NVS earnings call for the period ending December 31, 2023.

United statesAndrew baumSamir shahAndrew baum citiJohn priestner jpmorganRichard parkesKerry holfordSociete generaleMark purcell morgan stanleyRichard parkes exanePeter welford jefferiesMatt westonFlorent cespedesMatthew westonGraham parryStephen scala

Royalty Pharma plc (NASDAQ:RPRX) Q3 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Royalty Pharma Third Quarter 2023 Earnings Conference Call.

Chris schottStephen scalaGeorge grofikChristopher schottAndrew baumMarshall uristPablo legorretaTerrance coyneTerry coyneRepros therapeutics incLife sciencesHead of researchRoyalty pharmaCall transcript novemberRoyalty pharma third quarterSenior vice president

vimarsana © 2020. All Rights Reserved.